MilliporeSigma

MilliporeSigma

生物技术研究

Burlington,MA 200,155 位关注者

Together, we impact life and health with science.

关于我们

Together with our colleagues, customers and stakeholders, we impact life and health with science. Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise to perform experiments and engineer new products. That’s where we come in. We offer one of the broadest portfolios in the industry for scientists, best-in-class products for pharmaceutical development and manufacturing, and a fully integrated service organization to support CDMO and contract testing across traditional and novel modalities. Our vision is a world where our innovative products, services and digital offerings help create solutions for people globally and a sustainable future for generations to come. The life science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada. Merck KGaA, Darmstadt, Germany is a global science and technology company with around 60,000 employees in more than 66 countries. Intended only for US/CA visitors.

网站
https://www.sigmaaldrich.com
所属行业
生物技术研究
规模
超过 10,001 人
总部
Burlington,MA
类型
上市公司
创立
1668
领域
Life Science Research、Drug Discovery & Development、Lab Filtration、Lab Water、Bioscience、Upstream & Downstream Bioprocessing、BioMonitoring、Lab Solutions、Life Sciences和Process Solutions

地点

MilliporeSigma员工

动态

  • 查看MilliporeSigma的公司主页,图片

    200,155 位关注者

    We’re saving 3 million sheets of paper with a small change. Here’s how?? Quality is our top priority, so nearly every product shipped comes with a Certificate of Quality. At our Jaffrey, NH site, we’ve switched from paper slips to QR codes, saving 3 million sheets of paper each year. We plan to expand this initiative to other distribution sites in the future. Read about other projects to make our packaging greener here: https://ms.spr.ly/6041mPdK7

    • 该图片无替代文字
  • 查看MilliporeSigma的公司主页,图片

    200,155 位关注者

    We're teaming up with ABC’s Abbott Elementary to bring our Curiosity Cube—a solar-powered mobile science lab—to more students across the U.S.! This exciting collaboration means more students nationwide will get hands-on STEM experiences in cities like Boston, Houston, New York City, Philadelphia, and Washington, D.C. Together, we're inspiring the next generation of scientists. Don’t miss the season premiere of Abbott Elementary on Wednesday, October 9, at 9:30/8:30c on ABC and Stream on Hulu. Learn more: https://ms.spr.ly/6045mMhBR #SPARKCuriosity #AbbottElementary

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • 查看MilliporeSigma的公司主页,图片

    200,155 位关注者

    What if we could tell our bodies to fight off HIV, flu, or cancer? RNA therapeutics have the potential to do just that, but they are fragile and easily broken down in the body before reaching their destination. This is where lipid nanoparticles (LNP), the protective carriers for RNA come in. Scientists like Johanna Simon — along with her colleagues from our Early Formulation Screening Service Team — help clients identify and create customized LNP. By finding the right protective carrier to deliver RNA, their therapeutics are more likely to work. Learn how Johanna and her colleagues can support bringing ideas from discovery to an impactful product for patients here: https://ms.spr.ly/6041mMChR

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • 查看MilliporeSigma的公司主页,图片

    200,155 位关注者

    We are thrilled to launch the FIRST single-use reactor specifically designed to manufacture antibody-drug conjugates (ADCs). The new Mobius ADC Reactor enables biopharmaceutical companies to produce their critical therapies faster and safer. ADCs are a groundbreaking technology that targets and selectively kills tumor cells while protecting healthy ones. This new reactor is tailored precisely to meet the unique requirements for ADC manufacturing. By embracing single-use technology, the new Mobius ADC Reactor can boost manufacturing efficiency by 70% compared to traditional methods. Learn more about this innovation here: https://ms.spr.ly/6040mzQZg

    • 该图片无替代文字
  • 查看MilliporeSigma的公司主页,图片

    200,155 位关注者

    A researcher creates a new test for an old disease. Read her story: https://ms.spr.ly/6045mDT5b Testing for Hansen’s disease—formerly known as Leprosy—used to be confined to specialized clinics. It was difficult to get tested, diagnosed, and treated, especially in remote areas, where hotspots tend to occur. Motivated by the experience of someone close to her, one researcher set out to create a more accessible testing option.

    • 该图片无替代文字
  • 查看MilliporeSigma的公司主页,图片

    200,155 位关注者

    Big news! We're the FIRST in the industry to receive EXCiPACT cGMP certification for cell culture manufacturing. This certification highlights our commitment to the safety, quality, and efficacy of cell culture media used in drug components. Cell culture media is an essential raw material used in life-saving therapies and processes as varied as gene therapy, vaccine, and monoclonal antibody manufacturing. Because of its central role in biomanufacturing, a consistent supply of high-quality media is required to deliver the necessary concentration and protein quality for therapeutics. More on this news here: https://ms.spr.ly/6047mBFMf

    • Cell culture media is an essential raw material used in the manufacture of life-saving therapies and in processes as varied as vaccine manufacturing, gene therapy, and monoclonal antibody manufacturing.

关联主页

相似主页

查看职位